Spectrum of diverse genomic alterations define non–clear cell renal carcinoma subtypes

[1]  C. Ahn,et al.  Two case reports , 2017, Medicine.

[2]  Lawrence A. Donehower,et al.  The somatic genomic landscape of chromophobe renal cell carcinoma. , 2014, Cancer cell.

[3]  M. McInnes,et al.  Diagnostic accuracy of segmental enhancement inversion for the diagnosis of renal oncocytoma using biphasic computed tomography (CT) and multiphase contrast-enhanced magnetic resonance imaging (MRI) , 2014, European Radiology.

[4]  Erika J. Thompson,et al.  Next-Generation Sequencing of Translocation Renal Cell Carcinoma Reveals Novel RNA Splicing Partners and Frequent Mutations of Chromatin-Remodeling Genes , 2014, Clinical Cancer Research.

[5]  F. Jordan,et al.  The Pyruvate Dehydrogenase Complexes: Structure-based Function and Regulation* , 2014, The Journal of Biological Chemistry.

[6]  R. Belmaker,et al.  Inositol-Related Gene Knockouts Mimic Lithium’s Effect on Mitochondrial Function , 2011 .

[7]  J. Brugarolas,et al.  Simultaneous isolation of high-quality DNA, RNA, miRNA and proteins from tissues for genomic applications , 2013, Nature Protocols.

[8]  Lars Egevad,et al.  The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia , 2013, The American journal of surgical pathology.

[9]  Osamu Takeuchi,et al.  Strawberry notch homologue 2 regulates osteoclast fusion by enhancing the expression of DC-STAMP , 2013, The Journal of experimental medicine.

[10]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of clear cell renal cell carcinoma , 2013, Nature.

[11]  A. Hakimi,et al.  A clear picture of renal cell carcinoma , 2013, Nature Genetics.

[12]  H. Aburatani,et al.  Integrated molecular analysis of clear-cell renal cell carcinoma , 2013, Nature Genetics.

[13]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of clear cell renal cell carcinoma , 2013, Nature.

[14]  J. Bellmunt,et al.  Targeted therapies and the treatment of non-clear cell renal cell carcinoma. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[15]  G. Gyapay,et al.  Germline BAP1 mutations predispose to renal cell carcinomas. , 2013, American journal of human genetics.

[16]  C. Siegel Re: Renal cortical tumors: use of multiphasic contrast-enhanced MR imaging to differentiate benign and malignant histologic subtypes. , 2013, The Journal of urology.

[17]  N. Grishin,et al.  A Novel Germline Mutation in BAP1 Predisposes to Familial Clear-Cell Renal Cell Carcinoma , 2013, Molecular Cancer Research.

[18]  F. Palmieri The mitochondrial transporter family SLC25: identification, properties and physiopathology. , 2013, Molecular aspects of medicine.

[19]  Y. Nagashima,et al.  Transition of organizational category on renal cancer. , 2013, Japanese journal of clinical oncology.

[20]  J. Zucman‐Rossi,et al.  Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I. , 2013, Journal of hepatology.

[21]  M. Stratton,et al.  Deciphering Signatures of Mutational Processes Operative in Human Cancer , 2013, Cell reports.

[22]  Keith T Flaherty,et al.  Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  A. Jemal,et al.  Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.

[24]  S. Gabriel,et al.  Analysis of 6,515 exomes reveals a recent origin of most human protein-coding variants , 2012, Nature.

[25]  Steven A. Roberts,et al.  Mutational heterogeneity in cancer and the search for new cancer-associated genes , 2013 .

[26]  W. Linehan,et al.  Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer. , 2012, The Journal of urology.

[27]  L. Stein,et al.  Annotating Cancer Variants and Anti-Cancer Therapeutics in Reactome , 2012, Cancers.

[28]  Robert Gentleman,et al.  Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer , 2012, Nature Genetics.

[29]  L. Schwartz,et al.  Renal cortical tumors: use of multiphasic contrast-enhanced MR imaging to differentiate benign and malignant histologic subtypes. , 2012, Radiology.

[30]  Melanie A. Huntley,et al.  Recurrent R-spondin fusions in colon cancer , 2012, Nature.

[31]  Matthew B. Callaway,et al.  MuSiC: Identifying mutational significance in cancer genomes , 2012, Genome research.

[32]  P. Bühlmann,et al.  Integrative genome-wide expression profiling identifies three distinct molecular subgroups of renal cell carcinoma with different patient outcome , 2012, BMC Cancer.

[33]  Navdeep S. Chandel,et al.  AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress , 2012, Nature.

[34]  N. Grishin,et al.  BAP1 loss defines a new class of renal cell carcinoma , 2012, Nature Genetics.

[35]  A. Børresen-Dale,et al.  Mutational Processes Molding the Genomes of 21 Breast Cancers , 2012, Cell.

[36]  Wendy S. W. Wong,et al.  Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs , 2012, Bioinform..

[37]  M. Papotti,et al.  Human achaete-scute homolog-1 expression in neuroendocrine breast carcinoma , 2012, Virchows Archiv.

[38]  P. Schirmacher,et al.  Molecular heterogeneity of TFE3 activation in renal cell carcinomas , 2012, Modern Pathology.

[39]  A. Imbard,et al.  Molecular characterization of 82 patients with pyruvate dehydrogenase complex deficiency. Structural implications of novel amino acid substitutions in E1 protein. , 2011, Molecular genetics and metabolism.

[40]  K. Brown,et al.  A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma , 2011, Nature.

[41]  Gang Wang,et al.  Generation of a mouse model of Von Hippel-Lindau kidney disease leading to renal cancers by expression of a constitutively active mutant of HIF1α. , 2011, Cancer research.

[42]  D. Fisher,et al.  Biology and clinical relevance of the micropthalmia family of transcription factors in human cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  S. Gamblin,et al.  AMP-activated protein kinase: nature's energy sensor. , 2011, Nature chemical biology.

[44]  Jill M Hagenkord,et al.  Clinical genomics of renal epithelial tumors. , 2011, Cancer genetics.

[45]  G. Tisone,et al.  Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: two case reports. , 2011, Transplantation proceedings.

[46]  A. Gonzalez-Perez,et al.  Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. , 2011, American journal of human genetics.

[47]  M. DePristo,et al.  A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.

[48]  Lincoln Stein,et al.  Reactome: a database of reactions, pathways and biological processes , 2010, Nucleic Acids Res..

[49]  J. Babb,et al.  MRI features of renal oncocytoma and chromophobe renal cell carcinoma. , 2010, AJR. American journal of roentgenology.

[50]  Jonathan W. Pillow,et al.  POSTER PRESENTATION Open Access , 2013 .

[51]  A. Young Editorial Comment from Dr Young to Molecular pathology of renal oncocytoma: A review , 2010, International journal of urology : official journal of the Japanese Urological Association.

[52]  M. Yusenko Molecular pathology of chromophobe renal cell carcinoma: A review , 2010, International journal of urology : official journal of the Japanese Urological Association.

[53]  A. Osunkoya Editorial Comment to Molecular pathology of chromophobe renal cell carcinoma: A review , 2010, International journal of urology : official journal of the Japanese Urological Association.

[54]  M. Yusenko Molecular pathology of renal oncocytoma: A review , 2010, International journal of urology : official journal of the Japanese Urological Association.

[55]  M. Picken Editorial Comment from Dr Picken to Molecular pathology of renal oncocytoma: A review , 2010, International journal of urology : official journal of the Japanese Urological Association.

[56]  W. Linehan,et al.  The genetic basis of kidney cancer: a metabolic disease , 2010, Nature Reviews Urology.

[57]  W. Huber,et al.  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets , 2011 .

[58]  Serban Nacu,et al.  Fast and SNP-tolerant detection of complex variants and splicing in short reads , 2010, Bioinform..

[59]  Mark D. Robinson,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[60]  Mingming Jia,et al.  COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer , 2009, Nucleic Acids Res..

[61]  S. Swamy,et al.  PICNIC: an algorithm to predict absolute allelic copy number variation with microarray cancer data , 2009, Biostatistics.

[62]  B. Peters,et al.  Somatic mutations in p85alpha promote tumorigenesis through class IA PI3K activation. , 2009, Cancer cell.

[63]  A. Ribes,et al.  PDH E1β deficiency with novel mutations in two patients with Leigh syndrome , 2009, Journal of Inherited Metabolic Disease.

[64]  Robert Gentleman,et al.  ShortRead: a bioconductor package for input, quality assessment and exploration of high-throughput sequence data , 2009, Bioinform..

[65]  B. Kemp,et al.  AMPK in Health and Disease. , 2009, Physiological reviews.

[66]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[67]  Börje Ljungberg,et al.  High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas , 2009, BMC Cancer.

[68]  Haixia Cheng,et al.  Hepatocyte growth factor activator inhibitor type 1 regulates epithelial to mesenchymal transition through membrane-bound serine proteinases. , 2009, Cancer research.

[69]  R. Dummer,et al.  Novel MITF targets identified using a two‐step DNA microarray strategy , 2008, Pigment cell & melanoma research.

[70]  H. Moch,et al.  Chromophobe Renal Cell Carcinoma: Histomorphologic Characteristics and Evaluation of Conventional Pathologic Prognostic Parameters in 145 Cases , 2008, The American journal of surgical pathology.

[71]  J. Zha,et al.  Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas. , 2008, Cancer research.

[72]  R. Dhir,et al.  Whole genome SNP arrays as a potential diagnostic tool for the detection of characteristic chromosomal aberrations in renal epithelial tumors , 2008, Modern Pathology.

[73]  R. Tibshirani,et al.  Spatial smoothing and hot spot detection for CGH data using the fused lasso. , 2008, Biostatistics.

[74]  M. Ladanyi,et al.  Xp11 Translocation Renal Cell Carcinoma in Adults: Expanded Clinical, Pathologic, and Genetic Spectrum , 2007, The American journal of surgical pathology.

[75]  F. Ross,et al.  Regulation of AMP‐activated protein kinase by a pseudosubstrate sequence on the γ subunit , 2007 .

[76]  S. Richard,et al.  Mutations in BHD and TP53 genes, but not in HNF1β gene, in a large series of sporadic chromophobe renal cell carcinoma , 2006, British Journal of Cancer.

[77]  Fabien Campagne,et al.  Gene Expression Profiling Separates Chromophobe Renal Cell Carcinoma from Oncocytoma and Identifies Vesicular Transport and Cell Junction Proteins as Differentially Expressed Genes , 2006, Clinical Cancer Research.

[78]  P. Zimmermann The prevalence and significance of PDZ domain-phosphoinositide interactions. , 2006, Biochimica et biophysica acta.

[79]  J. Schneider,et al.  Characterization of the role of gamma2 R531G mutation in AMP-activated protein kinase in cardiac hypertrophy and Wolff-Parkinson-White syndrome. , 2006, American journal of physiology. Heart and circulatory physiology.

[80]  Ben J. Powell,et al.  Structural characterization of autoinhibited c-Met kinase produced by coexpression in bacteria with phosphatase. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[81]  G. Pfeifer Mutagenesis at methylated CpG sequences. , 2006, Current topics in microbiology and immunology.

[82]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[83]  B. Burwinkel,et al.  Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency. , 2005, American journal of human genetics.

[84]  D. Pearce,et al.  Elevation of Hook1 in a disease model of Batten disease does not affect a novel interaction between Ankyrin G and Hook1. , 2005, Biochemical and biophysical research communications.

[85]  R Y Ball,et al.  Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs , 2005 .

[86]  N. Copeland,et al.  Melanocytes and the microphthalmia transcription factor network. , 2004, Annual review of genetics.

[87]  Pablo Tamayo,et al.  Metagenes and molecular pattern discovery using matrix factorization , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[88]  W. Gerald,et al.  Induction of BAIAP3 by the EWS-WT1 chimeric fusion implicates regulated exocytosis in tumorigenesis. , 2002, Cancer cell.

[89]  P. Bork,et al.  Human non-synonymous SNPs: server and survey. , 2002, Nucleic acids research.

[90]  S. Henikoff,et al.  Accounting for human polymorphisms predicted to affect protein function. , 2002, Genome research.

[91]  L. Schmidt,et al.  Structural basis of oncogenic activation caused by point mutations in the kinase domain of the MET proto‐oncogene: Modeling studies , 2001, Proteins.

[92]  Elizabeth M. Smigielski,et al.  dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..

[93]  R. Vink,et al.  Hepatocellular carcinoma in glycogen storage disease type IV , 2000, Archives of disease in childhood.

[94]  P. Cullen,et al.  Molecular Cloning and Functional Characterization of a Human Homologue of Centaurin-α , 1999 .

[95]  W. Linehan,et al.  Novel mutations of the MET proto-oncogene in papillary renal carcinomas , 1999, Oncogene.

[96]  S. Scherer,et al.  Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas , 1997, Nature Genetics.

[97]  P. Bugert,et al.  Mutation of the p53 tumour suppressor gene occurs preferentially in the chromophobe type of renal cell tumour , 1997, The Journal of pathology.

[98]  S. Bonsib,et al.  Papillary renal tumors. Morphologic, cytochemical, and genotypic features , 1995, Cancer.

[99]  James A. Vaught,et al.  microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. , 1994, Genes & development.

[100]  E. Medico,et al.  Phosphorylation of serine 985 negatively regulates the hepatocyte growth factor receptor kinase. , 1994, The Journal of biological chemistry.

[101]  G. Corrent,et al.  Metabolic disease , 2000, Dermatologic clinics.

[102]  Robert C. Wolpert,et al.  A Review of the , 1985 .

[103]  R. Siegel,et al.  Combined median and ulnar nerve lesions complicating fractures of the distal radius and ulna. Two case reports. , 1968 .

[104]  Ann Allergy,et al.  O R I G I N a L a R T I C L E S , 2022 .